Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1654-1661

  Dasgupta, Anindya ^a   Hammarlund, Erika ^a   Slifka, Mark K ^a   Früh, Klaus ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SMALLPOX VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; COMPLEMENT DEPENDENT CYTOTOXICITY; COWPOX VIRUS; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; SMALLPOX; SUPERINFECTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS VIRULENCE;

EID: 33846500919     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1654     Document Type: Article

References (43)

1. Lewis-Jones, S. 2004. Zoonotic poxvirus infections in humans. Curr. Opin. Infect. Dis. 17: 81-89.
2. Baxby, D., and M. Bennett. 1997. Cowpox: a re-evaluation of the risks of human cowpox based on new epidemiological information. Arch. Virol. 13: 1-12.
3. Meyer, H., H. Neubauer, and M. Pfeffer. 2002. Amplification of 'variola virus-specific' sequences in German cowpox virus isolates. J. Vet. Med. B. Infect Dis. Vet. Public Health 49: 17-19.
4. Shchelkunov, S. N., P. F. Safronov, A. V. Totmenin, N. A. Petrov, O. I. Ryazankina, V. V. Gutorov, and G. J. Kotwal. 1998. The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology 243: 432-460.
5. Upton, C., S. Slack, A. L. Hunter, A. Ehlers, and R. L. Roper. 2003. Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. J. Virol. 77: 7590-7600.
6. Smith, S. A., and G. J. Kotwal. 2002. Immune response to poxvirus infections in various animals. Crit. Rev. Microbiol 28: 149-185.
7. Hammarlund, E., M. W. Lewis, S. G. Hansen, L. I. Strelow, J. A. Nelson, G. J. Sexton, J. M. Hanifin, and M. K. Slifka. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9: 1131-1137.
8. Crotty, S., P. Feigner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171: 4969-4973.
9. Seet, B. T., J. B. Johnston, C. R. Brunetti, J. W. Barrett, H. Everett, C. Cameron, J. Sypula, S. H. Nazarian, A. Lucas, and G. McFadden. 2003. Poxviruses and immune evasion. Annu. Rev. Immunol. 21: 377-423.
10. Früh, K., E. Bartee, K. Gouveia, and M. Mansouri. 2002. Immune evasion by a novel family of viral PHD/LAP-finger proteins of γ-2 herpesviruses and poxviruses. Virus Research 88: 55-69.
11. Yewdell, J. W., and C. V. Nicchitta. 2006. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol 27: 368-373.
12. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184.
13. Saric, T., S. C. Chang, A. Hattori, I. A. York, S. Markant, K. L. Rock, M. Tsujimoto, and A. L. Goldberg. 2002. An [FN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-1176.
14. Cresswell, P., N. Bangia, T. Dick, and G. Diedrich. 1999. The nature of the MHC class I peptide loading complex. Immunol. Rev. 172: 21-28.
15. Gruhler, A., and K. Früh. 2000. Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones. Traffic 1: 306-311.
16. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
17. Früh, K., K. Ahn, H. Djaballah, P. Sempé, P. M. van Endert, R. Tampé, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
18. Koppers-Lalic, D., E. A. Reits, M. E. Ressing, A. D. Lipinska, R. Abele, J. Koch, M. Marcondes Rezende, P. Admiraal, D. van Leeuwen, K. Bienkowska-Szewczyk, et al. 2005. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA 102: 5144-5149.
19. Pande, N. T., C. Powers, K. Ahn, and K. Früh. 2005. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J. Virol. 79: 5786-5798.
20. Momburg, F., and H. Hengel. 2002. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. Curr. Top Microbiol. Immunol. 269: 57-74.
21. van der Wal, F. J., M. Kikkert, and E. Wiertz. 2002. The HCMV gene products US2 and US 11 target MHC class I molecules for degradation in the cytosol. Curr. Top. Microbiol. Immunol. 269: 37-55.
22. Brutkiewicz, R. R., S. J. Klaus, and R. M. Welsh. 1992. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression. Nat. Immun. 11: 203-214.
23. Letvin, N. L., J. E. Schmitz, H. L. Jordan, A. Seth, V. M. Hirsch, K. A. Reimann, and M. J. Kuroda. 1999. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus. Immunol. Rev. 170: 127-134.
24. Ahn, K., A. Angulo, P. Ghazal, P. A. Peterson, Y. Yang, and K. Früh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93: 10990-10995.
25. Harrington, L. E., R. van der Most, J. L. Whitton, and R. Ahmed. 2002. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 76: 3329-3337.
26. Mansouri, M., E. Bartee, K. Gouveia, B. T. Hovey Nerenberg, J. Barrett, L. Thomas, G. Thomas, G. McFadden, and K. Früh. 2003. The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J. Virol. 77: 1427-1440.
27. + T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201: 95-104.
28. + T-cell determinants and cross-reactivity in BALB/c mice. J. Virol. 80: 6318-6323.
29. Oseroff, C., F. Kos, H. H. Bui, B. Peters, V. Pasquetto, J. Glenn, T. Palmore, J. Sidney, D. C. Tscharke, J. R. Bennink, et al. 2005. HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc. Natl. Acad. Sci. USA 102: 13980-13985.
30. Schoenhals, G. J., R. M. Krishna, A. G. Grandea, III, T. Spies, P. A. Peterson, Y. Yang, and K. Früh. 1999. Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J. 18: 743-753.
31. Townsend, A., T. Elliott, V. Cerundolo, L. Foster, B. Barber, and A. Tse. 1990. Assembly of MHC class I molecules analyzed in vitro. Cell 62: 285-295.
32. Hughes, E. A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94: 1896-1901.
33. Vanderplasschen, A., E. Mathew, M. Hollinshead, R. B. Sim, and G. L. Smith. 1998. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. USA 95: 7544-7549.
34. Bennett, E. M., J. R. Bennink, J. W. Yewdell, and F. M. Brodsky. 1999. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162: 5049-5052.
35. Park, B., Y. Kim, J. Shin, S. Lee, K. Cho, K. Früh, and K. Ahn. 2004. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20: 71-85.
36. Park, B., S. Lee, E. Kim, K. Cho, S. R. Riddell, S. Cho, and K. Ahn. 2006. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127: 369-382.
37. Gold, M. C., M. W. Munks, M. Wagner, C. W. McMahon, A. Kelly, D. G. Kavanagh, M. K. Slifka, U. H. Koszinowski, D. H. Raulet, and A. B. Hill. 2004. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J. Immunol. 172: 6944-6953.
38. Guerin, J. L., J. Gelfi, S. Boullier, M. Delverdier, F. A. Bellanger, S. Bertagnoli, I. Drexler, G. Sutter, and F. Messud-Petit. 2002. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J. Virol. 76: 2912-2923.
39. Tulman, E. R., G. Delhon, C. L. Afonso, Z. Lu, L. Zsak, N. T. Sandybaev, U. Z. Kerembekova, V. L. Zaitsev, G. F. Kutish, and D. L. Rock. 2006. Genome of horsepox virus. J. Virol. 80: 9244-9258.
40. Studdert, M. J. 1989. Experimental vaccinia virus infection of horses. Aust. Vet. J. 66: 157-159.
41. Tizard, I. 1999. Grease, anthraxgate, and kennel cough: a revisionist history of early veterinary vaccines. Adv. Vet. Med. 41: 7-24.
42. Edghill-Smith, Y., H. Golding, J. Manischewitz, L. R. King, D. Scott, M. Bray, A. Nalca, J. W. Hooper, C. A. Whitehouse, J. E. Schmitz, et al. 2005. Smallpox vaccine-induced antibodies are necessary and sufficient for pretection against monkeypox virus. Nat. Med. 11: 740-747.
43. Slifka, M. K. 2004. Immunological memory to viral infection. Curr. Opin. Immunol. 16: 443-450.